International Journal of Molecular Sciences Review Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases Siarhei A. Dabravolski 1,*, Evgeny E. Bezsonov 2,3 , Mirza S. Baig 4, Tatyana V. Popkova 5 and Alexander N. Orekhov 2,3 1 Department of Clinical Diagnostics, Vitebsk State Academy of Veterinary Medicine (UO VGAVM), 7/11 Dovatora Street, 210026 Vitebsk, Belarus 2 Laboratory of Cellular and Molecular Pathology of Cardiovascular System, Institute of Human Morphology, 3 Tsyurupa Street, 117418 Moscow, Russia;
[email protected] (E.E.B.);
[email protected] (A.N.O.) 3 Laboratory of Angiopathology, The Institute of General Pathology and Pathophysiology, 8 Baltiyskaya Street, 125315 Moscow, Russia 4 Department of Biosciences and Biomedical Engineering (BSBE), Indian Institute of Technology Indore (IITI), Simrol 453552, India;
[email protected] 5 V.A. Nasonova Institute of Rheumatology, 34A Kashirskoye Shosse, 115522 Moscow, Russia;
[email protected] * Correspondence:
[email protected] Abstract: The prevalence of NAFLD (non-alcoholic fatty liver disease) is a rapidly increasing problem, affecting a huge population around the globe. However, CVDs (cardiovascular diseases) are the most common cause of mortality in NAFLD patients. Atherogenic dyslipidemia, characterized by plasma hypertriglyceridemia, increased small dense LDL (low-density lipoprotein) particles, and decreased HDL-C (high-density lipoprotein cholesterol) levels, is often observed in NAFLD patients. In this review, we summarize recent genetic evidence, proving the diverse nature of metabolic pathways Citation: Dabravolski, S.A.; involved in NAFLD pathogenesis. Analysis of available genetic data suggests that the altered Bezsonov, E.E.; Baig, M.S.; Popkova, T.V.; Orekhov, A.N.